Publications

<< back

• Selected publications of Dr. Luigi Naldi
  
  1.Naldi L. Clinical practice: Seborrheic dermatitis. N Engl J Med (in press)
  
  2.Naldi L. The search for effective and safe disease control in psoriasis. Lancet. 2008;371:1311-2
  
  3.Lecluse LL, Naldi L, Stern RS, Spuls PI. National Registries of Systemic Treatment for Psoriasis and the European 'Psonet' Initiative. Dermatology. 2008 Dec 11. [Epub ahead of print]
  
  4.Gallus S, Naldi L; the Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren. Br J Dermatol. 2008 159:433-8.
  
  5.Merito M, Largeron N, Cohet C, Timelli L, Boselli F, Matteelli A, Naldi L, Vittori G. Treatment patterns and associated costs for genital warts in Italy. Curr Med Res Opin. 2008 Oct 10. [Epub ahead of print]
  
  6.Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, Maccarone M, Chatenoud L, Bertuccio P, Caggese E, Cuscito R. Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis. Evidence from the Psocare Project. Dermatology. 2008;217:365-373.
  
  7.Naldi L. Assessment of the risk of fragrance allergy in the general population: challenges and methodological issues. Drug Saf. 2008;31(5):440-3.
  
  8.Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomoni G, Naldi L. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol. 2008;159:1186-91.
  
  9.Ingordo V, Iannazzone SS, Cusano F, Naldi L. Reproducibility of dermoscopic features of congenital melanocytic nevi. Dermatology. 2008;217:231-4.
  
  10. Naldi L, Chatenoud L, Belloni A, et al. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology. 2008;216:125-30.
  
  11.Pelucchi C, Naldi L, Di Landro A, et al. Anthropometric measures, medical history and risk of basal cell carcinoma in an Italian case-control study. Dermatology. 2008;216:271-6.
  
  12.Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; for the RegiSCAR study group. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008;18:99-107.
  
  13.Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A,Naldi L, Dunant A, Viboud C, Roujeau JC; for the EuroSCAR Study Group. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2007;58:25-32.
  
  14. Naldi L, Gambini D. The clinical spectrum of psoriasis. Clin Dermatol. 2007;25:510-8.
  
  15.Naldi L. Health-related quality of life: from health economics to bedside? Dermatology. 2007;215(4):273-6.
  
  16.Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, Mockenhaupt M, Fagot JP, Roujeau JC. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157:989-96. Epub 2007 Sep 13.
  
  17.Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35-44.
  
  18.Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L. The 'EpiEnlist' project: a dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions. J Eur Acad Dermatol Venereol. 2007;21:1091-6.
  
  19. Gallus S, Naldi L, Carli P, La Vecchia C; Italian Group for Epidemiologic Research in Dermatology (GISED). Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy.Am J Epidemiol. 2007;166:472-8.
  
  20.Farina C, Gotti E, Parma A, Naldi L, Goglio A. Pheohyphomycotic soft tissue disease caused by Alternaria alternata in a kidney transplant patient: a case report and literature review. Transplant Proc. 2007;39:1655-9. Review.
  
  21.Lira MG, Mazzola S, Tessari G, Malerba G, Ortombina M, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Girolomoni G, Turco A. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation. Br J Dermatol. 2007;157:49-57.
  
  22.Naldi L, Chatenoud L, Bertuccio P, Zinetti C, Di Landro A, Scotti L, La Vecchia C; Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).Improving sun-protection behavior among children: results of a cluster-randomized trial in Italian elementary schools. The "SoleSi SoleNo-GISED" Project. J Invest Dermatol. 2007;127:1871-7.
  
  23. Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R, Abeni D, Tessari GP, Feltkamp MC, Claudy A, Stockfleth E, Harwood CA; EPI-HPV-UV-CA group. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol. 2007;127:1647-56.
  
  24.Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L. Congenital melanocytic nevus: an epidemiologic study in Italy. Dermatology. 2007;214:227-30.
  
  25.Tartaglia S, Belloni-Fortina A, Stefano P, Tessari G, Naldi L, Tenconi R, Clementi M. The +61 A-G polymorphism of the epidermal growth factor gene is not associated with occurrence of non-melanocytic skin tumors in transplant recipients.J Dermatol Sci. 2007;46:147-9.
  
  26. Williams HC, Naldi L, Paul C, Vahlquist A, Schroter S, Jobling R. Conflicts of interest in dermatology. Acta Derm Venereol. 2006;86:485-97.
  
  27.Tessari G, Naldi L, Boschiero L, Cordiano C, Piaserico S, Fortina AB, Cerimele D, La Parola IL, Capuano M, Gotti E, Ruggenenti P, Sassi F, Remuzzi G, Girolomoni G. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol. 2006 Sep-Oct;16(5):553-7.
  
  28. Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M, Turco A, Girolomoni G, Tessari G. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol. 2006 Dec;15(12):958-65.
  
  29. Pelucchi C, Di Landro A, Naldi L, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Risk factors for histological types and anatomic sites of cutaneous basal-cell carcinoma: an italian case-control study. J Invest Dermatol. 2007;127(4):935-44.
  
  30. Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2006 Jun;(15):2249-83.
  
  31. Naldi L, Randi G, Di Landro A, La Vecchia C. Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy. Arch Dermatol. 2006 Jul;142(7):935-6.
  
  32. Naldi L, Chatenoud L. Psoriasis and cancer: more than a chance link. Ann Dermatol Venereol. 2006;133(3):221-3.
  
  33. Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C; Prevalence of Actinic Keratoses Italian Study (PraKtis) Group. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses
  Italian Study, 2003-2004. Arch Dermatol. 2006 Jun;142(6):722-6.
  
  34. Jobling R, Naldi L. Assessing the impact of psoriasis and the relevance of qualitative research. J Invest Dermatol. 2006 Jul;126(7):1438-40.
  
  35. Naldi L, Manfrini R, Martin L, Deligant C, Dri P. Feasibility of a web-based continuing medical education program in dermatology: the DermoFAD experience in Italy. Dermatology. 2006;213(1):6-11.
  
  36. Langan SM, Bouwes Bavinck JN, Coenraads PJ, Diepgen T, Elsner P, Grob JJ, Linder D, Naldi L, Svensson A, Williams HC; European Dermato-Epidemiology
  Network. Update on the activities of the European Dermato-Epidemiology Network (EDEN). Dermatology. 2006;213(1):1-2.
  
  37.Ingordo V, Iannazzone SS, Cusano F, Naldi L. Dermoscopic features of congenital melanocytic nevus and Becker nevus in an adult male population: an analysis with a 10-fold magnification. Dermatology. 2006;212(4):354-60.
  
  38. Randi G, Naldi L, Gallus S, Di Landro A, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol. 2006 Sep;126(9):2106-10.
  
  39.Williams H, Svensson A, Diepgen T, Naldi L, Coenraads PJ, Elsner P, Grob JJ,
  Bouwes Bavinck JN; European Dermato-Epidemiology Network (EDEN). Epidemiology of skin diseases in Europe. Eur J Dermatol. 2006 Mar-Apr;16(2):212-8. No abstract available.
  
  40.Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C,
  Doria A. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S72-8. Review.
  
  41.Gallus S, Naldi L, Martin L, Martinelli M, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res. 2006;16(1):83-7.
  
  42.Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2005 Jun;(13):2070-98.
  
  43.Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control. 2005 Oct;16(8):893-9.
  
  44.Naldi L, Chatenoud L. Psoriasis. N Engl J Med. 2005;353:848-50.
  
  45.La Vecchia C, Gallus S, Naldi L. Tobacco and skin disease. Dermatology. 2005;211(2):81-3.
  
  46.Naldi L, Altieri A, Imberti GL, Giordano L, Gallus S, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol. 2005;15(7):545-50.
  
  47.Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125(1):61-7.
  
  48.Naldi L, Griffiths CE. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol. 2005;152(4):597-615.
  
  49.Tessari G, Forni A, Naldi L, Faggian G, Mazzucco A, Barba A. Malignant melanoma in a candidate for heart transplantation. Dermatology. 2005;210(3):233-6.
  
  50.Naldi L. A new era in the management of psoriasis? Promises and facts. Dermatology. 2005;210(3):179-81.
  
  51.Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2004 Jun;(11):2140-67.
  
  52.Naldi L, Gallus S, Tavani A, Imberti GL, La Vecchia C; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev. 2004;13(6):503-8.
  
  53.Ingordo V, Naldi L, Fracchiolla S, Colecchia B. Prevalence and risk factors for superficial fungal infections among Italian Navy Cadets. Dermatology. 2004;209(3):190-6.
  
  54.Van Coevorden AM, Coenraads PJ, Svensson A, Bavinck JN, Diepgen TL, Naldi L, Elsner P, Williams HC; European Dermato-Epidemiology Network (Eden). Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol. 2004 Aug;151(2):446-51. Review.
  
  55.Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 2004 Aug;14(4):301-9.
  
  56.Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3(2):121-8. Review.
  
  57.Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C; PraKtis Study Centers. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology. 2004;208(1):38-42.
  
  58.Ingordo V, Naldi L, Colecchia B, Licci N. Prevalence of pityriasis versicolor in young Italian sailors. Br J Dermatol. 2003 Dec;149(6):1270-2.
  
  59.Ingordo V, D'Andria G, Gentile C, Decuzzi M, Mascia E, Naldi L. X-linked ichthyosis in southern Italy. J Am Acad Dermatol. 2003 Nov;49(5):962-3.
  
  60.Oncology Cooperative Group Of The Italian Group For Epidemiologic Research In Dermatology (GISED). Improving sun protection behaviour in children: study design and baseline results of a randomized trial in Italian elementary schools. The 'Sole Si Sole No GISED' project. Dermatology. 2003;207(3):291-7.
  
  61.Ingordo V, D'Andria G, Gentile C, Decuzzi M, Mascia E, Naldi L. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology. 2003;207(2):148-50.
  
  62.Naldi L. Counting genetic skin disease in the population. Dermatology. 2003;207(2):125-6.
  
  63.Naldi L, Svensson A, Diepgen T, Elsner P, Grob JJ, Coenraads PJ, Bavinck JN, Williams H; European Dermato-Epidemiology Network. Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol. 2003;120(5):738-41.
  
  64.Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2002 Dec;(8):1688-708.
  
  65.Braun RP, Rabinovitz HS, Krischer J, Kreusch J, Oliviero M, Naldi L, Kopf AW, Saurat JH. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol. 2002 Dec;138(12):1556-60.
  
  66.Naldi L, Saurat JH. Dermatology launches the 'Evidence-Based Case Report' section. Dermatology. 2002;205(3):224-5.
  
  67.Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2002 Jun;(7):1488-507.
  
  68.Naldi L. Alefacept for psoriasis: promising drug, open questions. Arch Dermatol. 2002 Sep;138(9):1238-40.
  
  69.Campanelli A, Naldi L. A retrospective study of the effect of long-term topical application of retinaldehyde (0.05%) on the development of actinic keratosis. Dermatology. 2002;205(2):146-52.
  
  70.Carli P, Naldi L, Lovati S, La Vecchia C; Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer. 2002;101(4):375-9.
  
  71.Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC; SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002 Aug;138(8):1019-24.
  
  72.Naldi L. The epidemiology of fragrance allergy: questions and needs. Dermatology. 2002;205(1):89-97.
  
  73.Naldi L, Braun R, Saurat JH. Evidence-based dermatology: a need to reset the agenda. Dermatology. 2002;204(1):1-3.
  
  74.Naldi L. Turner's syndrome, melanocytic nevi and melanoma. Dermatology. 2001;203(3):275.
  
  75.Naldi L. Does clinical research help pemphigus patients? Precautions and suggestions. Dermatology. 2001;203(3):199-200.
  
  76.Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; EuroSCAR Study Group. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS. 2001 Sep 28;15(14):1843-8.
  
  77.Naldi L, Peli L, Parazzini F, Carrel CF; Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol. 2001 Mar;44(3):433-8.
  
  78.Naldi L, Minelli C. Exploring the causes of cutaneous B-cell lymphoma: we should learn from the Lyme disease experience. Dermatology. 2000;201(4):353-5.
  
  79.Ingordo V, Fracchiolla S, Figliola F, D'Andria G, Colecchia B, Naldi L. Prevalence and awareness of tinea pedis in Italian sailors. Dermatology. 2000;201(4):349-50.
  
  80.Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, Schena D, Diociaiuti A, Nanni G, La Parola IL, Masini C, Piaserico S, Peserico A, Cainelli T, Remuzzi G. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation. 2000 Nov 27;70(10):1479-84.
  
  81.Naldi L, Lovati S, Farina C, Gotti E, Cainelli T. Paecilomyces marquandii cellulitis in a kidney transplant patient. Br J Dermatol. 2000 Sep;143(3):647-9. Review.
  
  82.Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000;88(12):2703-10.
  
  83.Naldi L, Gallus S, Imberti GL, Cainelli T, Negri E, La Vecchia C. Sunscreens and cutaneous malignant melanoma: an Italian case-control study. Int J Cancer. 2000 Jun 15;86(6):879-82.
  
  84.Naldi L, Gallus S, Imberti GL, Cainelli T, Negri E, La Vecchia C. Sunlamps and sunbeds and the risk of cutaneous melanoma. Italian Group for Epidemiological Research in Dermatology.Eur J Cancer Prev. 2000 Apr;9(2):133-4.
  
  85.Naldi L, DiLandro A, D'Avanzo B, Parazzini F. Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol. 2000 Mar;42(3):446-52.
  
  86.Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol. 1999 Dec;135(12):1479-84.
  
  87.Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, Cocci A, Moretti U, Velo G, Leone R. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol. 1999;48(6):839-46.
  
  88.Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet. 1999;353(9171):2190-4.
  
  89.Williams HC, Po AL, Murrel D, Naldi L, Diepgen T. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol. 1998 Oct;139(4):757-8.
  
  90.Carli P, De Giorgi V, Naldi L, Dosi G. Reliability and inter-observer agreement of dermoscopic diagnosis of melanoma and melanocytic naevi. Dermoscopy Panel. Eur J Cancer Prev. 1998 Oct;7(5):397-402.
  
  91.Williams H, Adetugbo K, Po AL, Naldi L, Diepgen T, Murrell D. The Cochrane Skin Group. Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology. Arch Dermatol. 1998 Dec;134(12):1620-6.
  
  92.Naldi L. Cigarette smoking and psoriasis. Clin Dermatol. 1998;16(5):571-4.
  
  93.Rzany B, Naldi L, Schäfer T, Stern R, Williams H. The diagnosis of psoriasis: diagnostic criteria. Br J Dermatol. 1998 May;138(5):917.
  
  94.Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, Lebwohl M, Lew R, Naldi L, Parrish JA, Piepkorn M, Stern RS, Weinstein GD, Whitmore SE. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol. 1998 May;134(5):595-8.
  
  95.Nobili A, Gebru F, Rossetti A, Schettino F, Zahn RW, Nicolis E, Macario G, Celani L, Acik VO, Farina M, Naldi L. Doctorline: a private toll-free telephone medical information service. Five years of activity: old problems and new perspectives. Ann Pharmacother. 1998 Jan;32(1):120-5.
  
  96.Di Landro A, Marchesi L, Naldi L, Motta T, Cainelli T. A case of hypopigmented mycosis fungoides in a young Caucasian boy. Pediatr Dermatol. 1997 Nov-Dec;14(6):449-52.
  
  97.Conforti A, Gugliemo L, Naldi L, Cocci A, Venegoni M, Leone R. Brodimoprim: adverse drug reactions from spontaneous reporting. Br J Clin Pharmacol. 1997 Oct;44(4):411.
  
  98.Naldi L. Psoriasis: latest advances in understanding and novel therapeutic approaches. Expert Opin Investig Drugs. 1997 Jul;6(7):895-8.
  
  99.Naldi L, Colombi A. News from dermatology. Riv Inferm. 1997 Jan-Mar;16(1):41-7. Italian.
  
  100.Di Landro A, Naldi L, Locati F, Marchesi L, Cainelli T. Nodular lesions on fingertips. Diagnosis: cutaneous sarcoidosis. Arch Dermatol. 1996 Apr;132(4):460, 463.
  
  101.Naldi L, Adamoli L, Fraschini D, Corbetta A, Imberti L, Reseghetti A, Reciputo A, Rossi E, Cainelli T, Masera G. Number and distribution of melanocytic nevi in individuals with a history of childhood leukemia. Cancer. 1996 Apr 1;77(7):1402-8.
  
  102.Parazzini F, D'Oro LC, Naldi L, Bianchi C, Chatenoud L, Ricci E, Cainelli T, Pansera B, Mezzanotte C, Tessari GP, Locatelli A. Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol. 1996 Mar;76(2):147-9.
  
  103.Cutaneous reactions to alimentary tract medications: results of a seven-year surveillance program and review of the literature. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Dermatology. 1996;193(1):11-6. Review.
  
  104.Naldi L, Parazzini F, Peli L, Chatenoud L, Cainelli T. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol. 1996 Jan;134(1):101-6.
  
  105.Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995 Dec 14;333(24):1600-7.
  
  106.Parazzini F, Cavalieri D'oro L, Naldi L, Bianchi C, Graefembergh S, Mezzanotte C, Pansera B, Schena D, La Vecchia C, Franceschi S. Number of sexual partners, condom use and risk of human immunodeficiency virus infection. Int J Epidemiol. 1995 Dec;24(6):1197-203.
  
  107.Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Correia O, Shapiro S, Kaufman DW. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol. 1995 Sep;48(9):1099-108.
  
  108.Naldi L. Psoriasis. Dermatol Clin. 1995 Jul;13(3):635-47.
  
  109.Naldi L, Locati F, Finazzi G, Barbui T, Cainelli T. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer. 1995 Jun 1;75(11):2784-5.
  
  110.d'Oro LC, Parazzini F, Naldi L, La Vecchia C. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med. 1994 Dec;70(6):410-7.
  
  111.Marchesi L, Naldi L, Locati F, Tribbia G, Pezzica E, Parma A, Cainelli T. Combined Clark's nevus. Am J Dermatopathol. 1994 Aug;16(4):364-71.
  
  112.Naldi L, Tognoni G, Cainelli T. Analytic epidemiology in psoriasis. J Invest Dermatol. 1994 Jun;102(6):19S-23S.
  
  113.Valsecchi R, Leighissa P, Piazzolla S, Naldi L, Cainelli T. Occupational contact dermatitis from propranolol. Contact Dermatitis. 1994 Mar;30(3):177.
  
  114.Reseghetti A, Tribbia G, Locati F, Naldi L, Marchesi L. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis fungoides. Dermatology. 1994;189(1):75-7.
  
  115.Brevi A, Naldi L, Cainelli T, Parazzini F. Prevalence and awareness of hepatitis B virus carrier status in Italy. Genitourin Med. 1993 Jun;69(3):241.
  
  116.Naldi L, Bertoni M, Cainelli T. Feasibility of a registry of pemphigus in Italy: two years experience. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED) Int J Dermatol. 1993 Jun;32(6):424-7.
  
  117.Marchesi L, Naldi L, Parma A, Locati F, Cainelli T. Agminate blue nevus combined with lentigo. A variant of speckled lentiginous nevus? Am J Dermatopathol. 1993 Apr;15(2):162-5.
  
  118. Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, Brevi A, Cainelli T, Barbui T. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis. 1993 Mar;52(3):219-22.
  
  119. GISED. Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology. 1993;186(3):164-9.
  
  120. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993 Jan;129(1):92-6.
  
  121. Naldi L, Brevi A, Cavalieri d'Oro L, Ferri C, Marchesi L, Cainelli T. Painful distal erythema and thrombocytosis. Erythromelalgia secondary to thrombocytosis. Arch Dermatol. 1993 Jan;129(1):105-6, 109.
  
  122.Parazzini F, D'oro LC, Bianchi C, Mezzanotte C, Naldi L, Imberti GL, Pansera B, Cainelli T, Carlino A, Graefemberghi S. Determinants of hepatitis B virus surface antigen positivity in adults attending sexually transmitted disease clinics in Italy. Genitourin Med. 1992 Oct;68(5):345-6.
  
  123.Naldi L, Bronzoni M, d'Oro LC, Locati F, Marchesi L, Cainelli T. Figurate erythema, photosensitivity, and conjunctival irritation of recent onset. Subacute cutaneous lupus erythematosus (SCLE) and keratoconjunctivitis sicca. Arch Dermatol. 1992 Sep;128(9):1265, 1268.
  
  124.Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, Rossi E, Marinaro P, Polenghi MM, Finzi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992 Sep;127(3):212-7.
  
  125. Marchesi L, Naldi L, Di Landro A, Cavalieri d'Oro L, Brevi A, Cainelli T. Segmental lentiginosis with "jentigo" histologic pattern. Am J Dermatopathol. 1992 Aug;14(4):323-7. Review.
  
  126. Naldi L, Marchesi L, Locati F, Berti E, Cainelli T. Unusual manifestations of primary cutaneous amyloidosis in association with Raynaud's phenomenon and livedo reticularis. Clin Exp Dermatol. 1992 Mar;17(2):117-20.
  
  127.Naldi L, Carrel CF, Parazzini F, D'Oro LC, Cainelli T. Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials. Int J Dermatol. 1992 Feb;31(2):126-30.
  
  128. Naldi L, Finazzi G, Brevi A, Cavalieri d'Oro L, Locati F, Marchesi L, Cainelli T, Barbui T. Antiphospholipid antibodies and melanoma: a link? Dermatology. 1992;184(2):156.
  
  129. Naldi L, Marchesi L, Locati F, Cainelli T. Multiple papular and nodular lesions in a tall woman. Nevoid basal cell carcinoma syndrome. Arch Dermatol. 1991 Nov;127(11):1717-8, 1720-1.
  
  130.Parazzini F, Naldi L, Sena P, Cavalieri d'Oro L, Bianchi C, Manganoni A, Pansera B, Gramenzi A, Goglio A, Cainelli T. Risk factors for HIV infection in adults attending sexually transmitted disease clinics in Italy. Int J Epidemiol. 1991 Sep;20(3):758-63.
  
  131.Naldi L, Rozzoni M, Finazzi G, Pini P, Marchesi L, Cainelli T. Etretinate therapy and thrombocytopenia. Br J Dermatol. 1991 Apr;124(4):395.
  
  132.Ferri C, Reseghetti A, Veraldi S, Cusano F, Naldi L, Caputo R, Cainelli T. Bamifylline induced exanthema. Ann Dermatol Venereol. 1991;118(9):635-6. French.
  
  133.GISED.Spontaneous monitoring of adverse reactions to drugs by Italian dermatologists: a pilot study. Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatologica. 1991;182(1):12-7.
  
  134.GISED.Study of lichen planus conducted by the IGESD: results, implications for clinical practice, prospects. Italian Group of Epidemiological Studies in Dermatology (IGESD)] G Ital Dermatol Venereol. 1990 Dec;125(12):563-7.
  
  135.Naldi L, Zucchi A, Brevi A, Cavalierid'Oro L, Cainelli T. Corticosteroids and post-herpetic neuralgia. Lancet. 1990 Oct 13;336(8720):947.
  
  136.Naldi L, Locati F, Marchesi L, Cainelli T. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol. 1990 Aug;126(8):1103-4.
  
  137.Naldi L, Parazzini F, Cainelli T. Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group. J Am Acad Dermatol. 1990 Apr;22(4):654-6.
  
  138.GISED. Lichen planus and liver diseases: a multicentre case-control study. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). BMJ. 1990 Jan 27;300(6719):227-30.
  
  139.Naldi L, Sena P, Cainelli T. About the association of lichen planus and psoriasis. Dermatologica. 1990;181(1):79-80.
  
  140.Naldi L, Marchesi L, Finazzi G, Locati F, Cainelli T. Antiphospholipid antibodies and necrotizing purpura. Dermatologica. 1990;180(4):272-5.
  
  141.Naldi L, Parazzini F, Sena P, Manganoni A, Pansera B, Cainelli T. Frequency of HIV infection in patients attending sexually transmitted disease clinics in Italy. Int J Epidemiol. 1989 Dec;18(4):999-1000.
  
  142.GISED. Case-control surveillance of Stevens-Johnson syndrome and Lyell's syndrome.Presentation of the GISED project. G Ital Dermatol Venereol. 1989 Oct;124(10):435-40.
  
  143.Valsecchi R, Cainelli T, Perticucci E, Gotti E, Viganò GB, Remuzzi G, Naldi
  L. Von Willebrand factor multimers in systemic scleroderma. G Ital Dermatol Venereol. 1989 May;124(5):193-6.
  
  144.Naldi L. The Italian Group for Epidemiological Studies in Dermatology and the pilot project on the etiology of lichen planus. G Ital Dermatol Venereol. 1987 Mar;122(3):77-83.
  
  145.Valsecchi R, Vicari O, Frigeni A, Foiadelli L, Naldi L, Cainelli T. Familial alopecia areata--genetic susceptibility or coincidence? Acta Derm Venereol. 1985;65(2):175-7.
  
  146.Moscato G, Naldi L, Candura F. Bronchial asthma due to spiramycin and adipic acid. Clin Allergy. 1984 Jul;14(4):355-61.
  
  147.Moscato G, Pelissero G, Marchetti R, Naldi L, Zecca E, Prestinoni A, Piacentino G, Mussi U. Study of a group of subjects occupationally exposed to tartaric acid. G Ital Med Lav. 1983 Sep;5(5):193-8.
  
  148.Moscato G, Aprile C, Gherson G, Maestrelli P, Polato R, Brunetti G, Naldi L. A new dosimeter for bronchial provocation tests: technical tests and in vitro tests. Med Lav. 1983;74(4):313-2.
  
  
  Books and book chapters
  
  1. Williams HC, Naldi L. Epidemiology of skin disease in Europe. In: White Book Dermatology in Europe, European Dermatology Forum, 2002
  
  2. Naldi L. Vitiligo: epidemiology. In Vitiligo, problems and solutions. Lotti T and Hercogova J, eds, Marcel Dekker 2004
  
  3. Naldi L. Dermatology. In: Textbook of Clinical Trials. Day S, Green SB, Machin D, eds. John Wiley & Sons 2004
  
  4. Williams HC, Naldi L, Diepgen T, Bigby M, Herxheimer A, Rzany B, eds. Evidence Based Dermatology BMJ Books 2003
  
  5. Naldi L. Epidemiology. In: Hidradenitis suppurativa. Revuz J, Jemec G, Leyden JJ eds. Springer 2006
  
  6. Naldi L. Dermatology. In: Textbook of Clinical Trials. Day S, Green SB, Machin D, eds. John Wiley & Sons 2nd ed. 2007
  
  7. Williams HC, Diepgen T, Bigby M, Herxheimer A, Naldi L, Rzany B, eds. Evidence Based Dermatology BMJ Books 2nd ed (in press)
  
  8. Naldi L, Diepgen T. Epidemiology of skin cancer. In: Lim HW, Hoenigsmann H, Hawk JLM.eds. Photodermatology, Informa Healthcare, New York, 2007